These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinicopathological study of gene rearrangement and microRNA expression of primary central nervous system diffuse large B-cell lymphomas. Zheng J, Xu J, Ma S, Sun X, Geng M, Wang L. Int J Clin Exp Pathol; 2013; 6(10):2048-55. PubMed ID: 24133582 [Abstract] [Full Text] [Related]
6. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas. Brown PJ, Wong KK, Felce SL, Lyne L, Spearman H, Soilleux EJ, Pedersen LM, Møller MB, Green TM, Gascoyne DM, Banham AH. Leukemia; 2016 Mar; 30(3):605-16. PubMed ID: 26500140 [Abstract] [Full Text] [Related]
11. PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas. Franco R, Scognamiglio G, Valentino E, Vitiello M, Luciano A, Palma G, Arra C, La Mantia E, Panico L, Tenneriello V, Pinto A, Frigeri F, Capobianco G, Botti G, Cerchia L, De Chiara A, Fedele M. Oncotarget; 2016 Sep 13; 7(37):59158-59172. PubMed ID: 27494852 [Abstract] [Full Text] [Related]
12. A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas. van der Meeren LE, Kluiver J, Rutgers B, Alsagoor Y, Kluin PM, van den Berg A, Visser L. PLoS One; 2019 Sep 13; 14(10):e0223260. PubMed ID: 31603917 [Abstract] [Full Text] [Related]
13. Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas. Georgiou K, Chen L, Berglund M, Ren W, de Miranda NF, Lisboa S, Fangazio M, Zhu S, Hou Y, Wu K, Fang W, Wang X, Meng B, Zhang L, Zeng Y, Bhagat G, Nordenskjöld M, Sundström C, Enblad G, Dalla-Favera R, Zhang H, Teixeira MR, Pasqualucci L, Peng R, Pan-Hammarström Q. Blood; 2016 Jun 16; 127(24):3026-34. PubMed ID: 27030389 [Abstract] [Full Text] [Related]
14. Immunohistochemical distinction of ABC and GCB in extranodal DLBCL is not reflected in mutation patterns. Hallas C, Preukschas M, Tiemann M. Leuk Res; 2019 Jan 16; 76():107-111. PubMed ID: 30360939 [Abstract] [Full Text] [Related]
19. The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma. Ruminy P, Etancelin P, Couronné L, Parmentier F, Rainville V, Mareschal S, Bohers E, Burgot C, Cornic M, Bertrand P, Lenormand B, Picquenot JM, Jardin F, Tilly H, Bastard C. Leukemia; 2011 Apr 16; 25(4):681-8. PubMed ID: 21233831 [Abstract] [Full Text] [Related]
20. Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth. Bujisic B, De Gassart A, Tallant R, Demaria O, Zaffalon L, Chelbi S, Gilliet M, Bertoni F, Martinon F. Blood; 2017 Apr 27; 129(17):2420-2428. PubMed ID: 28167662 [Abstract] [Full Text] [Related] Page: [Next] [New Search]